Advanced stent platform with pharmaceutical coating for coronary applications. Reduces restenosis risk while maintaining vessel patency in patients with coronary artery disease.
Manufactured by
Sonosemi Medical Co., Ltd.
China
Sonosemi Medical, founded in 2020 and headquartered in Shenzhen, is a National High-tech Enterprise and National Specialized "Little Giant" Enterprise focusing on vascular interventional diagnostics and therapeutics. Core products include coronary intravascular lithotripsy systems, peripheral intravascular lithotripsy systems, intracardiac echocardiography systems, and intravascular ultrasound diagnostic systems.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
NVENTRIC
South Korea · 1 relevant product
Freudenberg Medical Hemoteq GmbH
Germany · 8 relevant products
Relisys Medical Devices Ltd
India · 5 relevant products
49 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →13 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 109 closest product alternatives
NVENTRIC · South Korea
Coronary stents with pharmaceutical coating designed to prevent restenosis and promote vessel patency. These devices are used for treatment of coronary artery disease.
Freudenberg Medical Hemoteq GmbH · Germany
Specialized stents with controlled drug delivery coatings for sustained release of active pharmaceutical ingredients. Designed to prevent restenosis and maintain vessel patency with optimized clinical performance.
Relisys Medical Devices Ltd · India
A coronary stent coated with antiproliferative medication to reduce restenosis rates following percutaneous coronary intervention. Provides sustained drug delivery to the vessel wall over extended periods.
106 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products